Research impact
Over 65 years, we've invested more than £500 million in blood cancer research which has led to a long line of breakthroughs that have improved treatments and saved lives.
Together we’ve achieved an incredible amount in the last 65 years, but there’s still much more to be done before we see a day where blood cancer is finally beaten.
Our research impact on leukaemia
Our research impact on childhood leukaemia
Our research impact on myeloma
Our research impact on lymphoma
Our research impact across all blood cancers and beyond
How our research helps other types of cancers